ID   YES-6-Rf
AC   CVCL_C0WZ
SY   Yes-6-Rf
DR   Wikidata; Q114313268
RX   PubMed=26317542;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S530 ! YES-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
RX   PubMed=26317542; DOI=10.18632/oncotarget.4540; PMCID=PMC4694873;
RA   Chen Q.-R., Song S.-M., Wei S.-Z., Liu B., Honjo S., Scott A.,
RA   Jin J.-K., Ma L., Zhu H.-T., Skinner H.D., Johnson R.L., Ajani J.A.;
RT   "ABT-263 induces apoptosis and synergizes with chemotherapy by
RT   targeting stemness pathways in esophageal cancer.";
RL   Oncotarget 6:25883-25896(2015).
//